CN1257739C - Senshitong mixture for treating nephrolithiasis - Google Patents

Senshitong mixture for treating nephrolithiasis Download PDF

Info

Publication number
CN1257739C
CN1257739C CNB2003101208564A CN200310120856A CN1257739C CN 1257739 C CN1257739 C CN 1257739C CN B2003101208564 A CNB2003101208564 A CN B2003101208564A CN 200310120856 A CN200310120856 A CN 200310120856A CN 1257739 C CN1257739 C CN 1257739C
Authority
CN
China
Prior art keywords
radix
calculus
examples
senshitong
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2003101208564A
Other languages
Chinese (zh)
Other versions
CN1554415A (en
Inventor
乔桂凤
张军
王仁阳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2003101208564A priority Critical patent/CN1257739C/en
Publication of CN1554415A publication Critical patent/CN1554415A/en
Application granted granted Critical
Publication of CN1257739C publication Critical patent/CN1257739C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a traditional Chinese medicine preparation for treating urinary system calculus, which is composed of 13 Chinese herbal medicines, such as clematis root, twotooth achyranthes root, etc. The present invention has the advantages of conspicuous curative effect, no toxic and side effect, convenient material obtainment, simple preparation and lower cost.

Description

Nephrolith leads to mixture
The present invention relates to a kind of Chinese medicine preparation for the treatment of urinary system calculus.
Existing treatment urinary system calculus medicine, as urocalun capsules, emperor's oral lithagogue liquid etc., drawback such as it is very dissatisfied to exist renal function injury, curative effect, and preparation process is loaded down with trivial details and cost an arm and a leg.
Chinese medicine preparation of the present invention can more effectively be treated urinary system calculus, and is without any side effects, and draws materials conveniently, and preparation is simple, and cost is lower.Observe through 4 years clinical 965 examples, to the treatment of kidney, ureter, bladder, calculus of urethra, obtain good effect, total effective rate is 99%.Relevant situation is detailed as follows:
1, patient source: all case derives from general hospital outpatient service and inpatient.
2, patient profile: among the 965 routine patients, male's 598 examples, women's 367 examples; 42 examples below 20 years old, 21-30 year 65 examples, 31-40 year 435 examples, 41-50 year 317 examples, 51-60 year 82 examples, 24 examples more than 60 years old; The course of disease is in 763 examples of person below 1 year, 1-3 person's 129 examples, person's 73 examples more than 3 years.
3, case is gone into the group standard: according to general hospital medical diagnosis on disease standard, be diagnosed as urinary system calculus, sex, age, the course of disease are not limit, but renal dysfunction person except the palpus.
4, medicine is formed: Radix Clematidis, Spora Lygodii, each 5%-10% of live chickens Endothelium corneum, Radix Paeoniae Rubra, the Radix Astragali, each 5%-15% of Rhizoma Dioscoreae, Radix Glycyrrhizae, Pericarpium Citri Reticulatae, each 3%-10% of Cortex Magnoliae Officinalis, Radix Achyranthis Bidentatae, Wang Buliu, each 3%-15% of Herba Dianthi, Herba Lysimachiae 10-40%.13 flavor medicines add up to 100%.
Embodiment 1
Radix Clematidis, Spora Lygodii, each 30g of Radix Paeoniae Rubra, Radix Glycyrrhizae, Pericarpium Citri Reticulatae, each 10g of Cortex Magnoliae Officinalis, Radix Achyranthis Bidentatae, Wang Buliu, Herba Dianthi, live chickens Endothelium corneum, the Radix Astragali, each 15g of Rhizoma Dioscoreae, Herba Lysimachiae 90g is used for the treatment of ureteral calculus, with urinary tract obstruction, renal colic.
Embodiment 2,
Radix Clematidis, Spora Lygodii, Radix Paeoniae Rubra, the Radix Astragali, each 30g of Rhizoma Dioscoreae, Radix Glycyrrhizae, Pericarpium Citri Reticulatae, each 10g of Cortex Magnoliae Officinalis, Radix Achyranthis Bidentatae, Wang Buliu, Herba Dianthi, each 15g of live chickens Endothelium corneum, Herba Lysimachiae 60g.Be used for the treatment of kidney, ureter, bladder, calculus of urethra, renal colic, but do not have urinary tract obstruction.
Embodiment 3,
Radix Clematidis, Spora Lygodii, live chickens Endothelium corneum, Radix Paeoniae Rubra, the Radix Astragali, each 30g of Rhizoma Dioscoreae, Radix Glycyrrhizae, Pericarpium Citri Reticulatae, each 10g of Cortex Magnoliae Officinalis, Radix Achyranthis Bidentatae, Wang Buliu, each 15g of Herba Dianthi, Herba Lysimachiae 45g.Be used for the treatment of renal calculus, no urinary tract obstruction and renal colic.
5, pharmacological effect: in this preparation, Radix Clematidis has the hard masses softening and resolving effect, makes calculus loose, easier discharge; Herba Lysimachiae, Spora Lygodii, live chickens Endothelium corneum urolith-discharging and urolith-eliminating; The king does not stay, the Herba Dianthi promoting blood circulation and hemostasis; Spora Lygodii, Radix Paeoniae Rubra, Radix Glycyrrhizae expansion ureter, emergency is ended logical: Pericarpium Citri Reticulatae, Cortex Magnoliae Officinalis circulation of qi promoting help calculus to discharge; The Radix Astragali, Rhizoma Dioscoreae spleen invigorating QI invigorating, health invigorating is in order to calculus; The Radix Achyranthis Bidentatae priming reaches disease institute.All medicines share, and have good calculus dissolving and excreting effect.
6, formulation method: each medicine takes by weighing 10 times of amounts, put and decoct after 1.5 hours in the jacketed pan, inclining decocting liquid, decoct 1 hour once more after, inclining decocting liquid and pressed liquor, with the first time decocting liquid mix, placed 24 hours, and got supernatant concentration, add distilled water behind the autoclaving and allocate to 5000ml to 4000ml, pack in the 250ml vial of sterilizing, promptly get 20 bottles.
7, method of administration: simple renal calculus: each 50-80ml, every day 2 times; Ureteral calculus, hydronephrosis, renal colic: each 100-180ml, every day 2-3 time, treat that renal colic, hydrops disappear, and change into 80-120ml/ time.
8, efficacy evaluation: cure: the calculus emptying; Produce effects: have calculus to discharge; Effectively: do not see that calculus discharges, but renal colic, hydrops disappear; Invalid: clinical symptoms does not have improvement.
9, therapeutic outcome: (seeing the following form)
(unit: example)
Can find out by last table, with Chinese medicine preparation treatment urinary system calculus of the present invention, evident in efficacy.In taking this preparation process, needn't take other calculus medicine.Chinese medicine preparation of the present invention is without any side effects, and draws materials conveniently, and preparation is simple, and cost is lower.

Claims (1)

  1. A kind of Chinese medicine preparation for the treatment of urinary system calculus, make by following medicine by weight percentage: Radix Clematidis, Spora Lygodii, each 5%-10% of live chickens Endothelium corneum, Radix Paeoniae Rubra, the Radix Astragali, each 5%-15% of Rhizoma Dioscoreae, Radix Glycyrrhizae, Pericarpium Citri Reticulatae, each 3%-10% of Cortex Magnoliae Officinalis, Radix Achyranthis Bidentatae, Wang Buliu, each 3%-15% of Herba Dianthi, Herba Lysimachiae 10-40%.
CNB2003101208564A 2003-12-29 2003-12-29 Senshitong mixture for treating nephrolithiasis Expired - Fee Related CN1257739C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2003101208564A CN1257739C (en) 2003-12-29 2003-12-29 Senshitong mixture for treating nephrolithiasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2003101208564A CN1257739C (en) 2003-12-29 2003-12-29 Senshitong mixture for treating nephrolithiasis

Publications (2)

Publication Number Publication Date
CN1554415A CN1554415A (en) 2004-12-15
CN1257739C true CN1257739C (en) 2006-05-31

Family

ID=34338323

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2003101208564A Expired - Fee Related CN1257739C (en) 2003-12-29 2003-12-29 Senshitong mixture for treating nephrolithiasis

Country Status (1)

Country Link
CN (1) CN1257739C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103142752A (en) * 2013-02-08 2013-06-12 安耀苍 Urinary calculus treatment medicine and its preparation method
CN103127357B (en) * 2013-02-22 2014-04-16 嵊州市林美生物科技有限公司 Traditional Chinese medicine composition used for treating kidney stone, and preparation method and application thereof
CN107661385A (en) * 2017-10-27 2018-02-06 江华珍 A kind of Chinese medicine composition for treating calculi in urinary system and preparation method thereof

Also Published As

Publication number Publication date
CN1554415A (en) 2004-12-15

Similar Documents

Publication Publication Date Title
CN101199748A (en) Chinese medicine preparation for treating hematonosis
CN101062372A (en) Chinese herbal medicine preparation for dissolving hepatobiliary system calculi
CN1895490A (en) Production of Chinese medicine and its medicinal pillow for treating cervical spondylosis
CN1257739C (en) Senshitong mixture for treating nephrolithiasis
CN1207022C (en) Medicinal composition for promoting bone-fracture healing and bone-joint injure repairing
CN1262951A (en) Medicine for curing arthralgia-syndrome resulted from wind,cold and dampness and its preparation method
CN1846781B (en) Medicine for treating chronic pharyngitis
CN100471508C (en) Medicine for treating cardiac and cerebral vascular diseases and its prepn process
CN101028400A (en) Xue Shang Hua embrocation and its production
CN1669562A (en) Muscles and bones rehabilitation plaster and preparation method thereof
CN1251715C (en) Chinese traditional medicine for treating hemorrhoid bloody stool
CN1481870A (en) Compound traditional Chinese medicine preparation for treating intractable chronic constipation and preparation method thereof
CN1310664C (en) Chinese medicine capsule for treating cardiac and cerebral vascular diseases and its production process
CN1069058C (en) Compound medicament for treating chronic pelvic inflammation
CN1063083C (en) Anti-senility medicine and its preparation
CN1092968C (en) Pharmaceuticals for treating outer skin blood vessel diease in cold seasons
CN1281265C (en) Diuretic and menstruation-regulating medicine and its prepn
CN102178758A (en) Medicament for treating peripheral nerve of diabetes
CN1927349A (en) Traditional Chinese medicine for treating rheumatism and its preparing process
CN101049491A (en) Application of stomachic pill with cyperus and amomum
CN102836365A (en) Chinese medicinal composition for treating urinary system calculi and application thereof
CN1225271C (en) Medicine for curing hyperplasia disease of mamary glands
CN1059115C (en) Drug composition for curing osteoporosis
CN1164291C (en) Chinese proprietary for treating protrusion of lumber interverterbral disc and its prepn.
CN103536864B (en) Chinese herbal medicine drug treatment composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee